Drug Profile
Etanercept biosimilar - STC Biologics
Alternative Names: STC 102Latest Information Update: 17 Nov 2021
Price :
$50
*
At a glance
- Originator STC Biologics
- Class Anti-inflammatories; Antipsoriatics; Antirheumatics; Disease-modifying antirheumatics; Recombinant fusion proteins; Skin disorder therapies
- Mechanism of Action Immunosuppressants; Tumour necrosis factor alpha inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Autoimmune disorders
Most Recent Events
- 06 Jul 2015 Discontinued - Preclinical for Autoimmune disorders in USA (SC) (STC Biologics product pipeline, July 2015)